Recent years have witnessed groundbreaking progresses in the field of diabetes treatment, with a particular focus on GLP-1 receptor agonists. Among these novel therapies, retatrutide and trizepatide are emerging as https://gretaebpt476316.snack-blog.com/39124575/novel-therapeutic-targets-in-diabetes-retatrutide-and-trizepatide